HC Wainwright Comments on ReWalk Robotics Ltd.’s FY2028 Earnings (NASDAQ:LFWD)

ReWalk Robotics Ltd. (NASDAQ:LFWD) – Research analysts at HC Wainwright issued their FY2028 earnings per share estimates for shares of ReWalk Robotics in a research report issued to clients and investors on Monday, April 15th. HC Wainwright analyst S. Ramakanth expects that the company will post earnings per share of $3.15 for the year. HC Wainwright has a “Buy” rating and a $9.00 price objective on the stock. The consensus estimate for ReWalk Robotics’ current full-year earnings is ($1.82) per share.

ReWalk Robotics Trading Up 0.2 %

ReWalk Robotics stock traded up $0.01 during mid-day trading on Wednesday, reaching $5.00. 26,525 shares of the company were exchanged, compared to its average volume of 65,013. ReWalk Robotics has a twelve month low of $3.90 and a twelve month high of $9.10. The stock has a 50-day moving average price of $5.60. The stock has a market capitalization of $42.50 million, a price-to-earnings ratio of -1.74 and a beta of 1.99.

ReWalk Robotics (NASDAQ:LFWD) last posted its quarterly earnings data on Tuesday, February 27th. The company reported ($0.35) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.91) by $0.56. ReWalk Robotics had a negative return on equity of 28.19% and a negative net margin of 159.76%. The company had revenue of $6.88 million during the quarter, compared to analysts’ expectations of $7.20 million.

ReWalk Robotics Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic.